Genome & Company (KOSDAQ:314130)
South Korea · Delayed Price · Currency is KRW 6,660.00
-250.00 (-3.62%)
At close: Apr 9, 2026
176.35% (1Y)
| Market Cap | 232.39B +208.9% |
| Revenue (ttm) | 24.59B -11.4% |
| Net Income | -6.43B |
| EPS | -205.00 |
| Shares Out | 34.89M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 360,511 |
| Average Volume | 618,248 |
| Open | 6,910.00 |
| Previous Close | 6,910.00 |
| Day's Range | 6,500.00 - 6,950.00 |
| 52-Week Range | 2,290.00 - 10,180.00 |
| Beta | 0.56 |
| RSI | 37.12 |
| Earnings Date | Nov 14, 2025 |